Emerging roles of SPINK1 in cancer

K Räsänen, O Itkonen, H Koistinen… - Clinical …, 2016 - academic.oup.com
BACKGROUND Tumor-associated trypsin inhibitor (TATI) was originally isolated from the
urine of a patient with ovarian cancer. It was later shown to be produced by many other …

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment

AW Kurian, EE Hare, MA Mills, KE Kingham… - Journal of clinical …, 2014 - ascopubs.org
Purpose Multiple-gene sequencing is entering practice, but its clinical value is unknown. We
evaluated the performance of a customized germline-DNA sequencing panel for cancer-risk …

TATI as a biomarker

O Itkonen, UH Stenman - Clinica chimica acta, 2014 - Elsevier
Tumor-associated trypsin inhibitor (TATI)[also called serine peptidase inhibitor Kazal type1,
SPINK1 and, in the pancreas, pancreatic secretory trypsin inhibitor (PSTI)] inhibits trypsin …

JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation

F Wang, L He, P Huangyang, J Liang, W Si, R Yan… - PLoS …, 2014 - journals.plos.org
Jumonji domain-containing 6 (JMJD6) is a member of the Jumonji C domain-containing
family of proteins. Compared to other members of the family, the cellular activity of JMJD6 is …

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

YF Lee, LD Miller, XB Chan, MA Black, B Pang… - Breast Cancer …, 2012 - Springer
Introduction We developed an analytic strategy that correlates gene expression and clinical
outcomes as a means to identify novel candidate oncogenes operative in breast cancer …

Epigenetic silencing of miRNA-338-5p and miRNA-421 drives SPINK1-positive prostate cancer

V Bhatia, A Yadav, R Tiwari, S Nigam, S Goel… - Clinical Cancer …, 2019 - AACR
Abstract Purpose: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines
the second most recurrent and aggressive prostate cancer subtype. However, the underlying …

Germline mutations in 40 cancer susceptibility genes among C hinese patients with high hereditary risk breast cancer

JY Li, R Jing, H Wei, M Wang, Q Xiaowei… - … journal of cancer, 2019 - Wiley Online Library
Multigene panel testing of breast cancer predisposition genes have been extensively
conducted in Europe and America, which is relatively rare in Asia however. In this study, we …

Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis

BA Jee, JH Choi, H Rhee, S Yoon, SM Kwon, JH Nahm… - Cancer research, 2019 - AACR
Hepatocellular carcinoma (HCC) undergoes a stepwise progression from liver cirrhosis to
low-grade dysplastic nodule (LGDN), high-grade dysplastic nodule (HGDN), early HCC …

[HTML][HTML] SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization

T Suwa, M Kobayashi, Y Shirai, JM Nam, Y Tabuchi… - JCI insight, 2021 - ncbi.nlm.nih.gov
Hypoxia is associated with tumor radioresistance; therefore, a predictive marker for tumor
hypoxia and a rational target to overcome it have been sought to realize personalized …

Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression

R Rangel, SC Lee, K Hon-Kim Ban… - Proceedings of the …, 2016 - National Acad Sciences
Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype.
To better understand the genetic forces driving TNBC, we performed a transposon …